BioStem Technologies provides innovative perinatal tissue allografts for use in regenerative therapies. $BSEM
Fort Lauderdale, FL
Joined July 2020
- Tweets792
- Following142
- Followers314
- Likes42
BioStem Technologies retweeted
$BSEM @BSEM_Tech BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje® in Diabetic Foot Ulcers - Press Release: bit.ly/3LCkIns #OTC #OTCMarkets #StockMarket #BSEM #BioStem #Healthcare #Medical #PrismMediaWire #PressRelease
BioStem Technologies retweeted
.@BSEM_Tech $BSEM Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
#stockstowatch #stocksinfocus #smallcaps #investors
pcgadvisory.com/pcgnews/bios…
BioStem Technologies retweeted
.@BSEM_Tech $BSEM Initiates Nationwide Launch of AmnioWrap2™
#wound #woundwrap #stockstowatch #stocksinfocus #investors
prismmarketview.com/biostem-…
BioStem Technologies retweeted
$BSEM @BSEM_Tech BioStem Technologies Initiates Nationwide Launch of AmnioWrap2™ with Venture Medical - Press Release: bit.ly/46hB1xO #OTC #OTCMarkets #StockMarket #PrismMediaWire #Medical #Healthcare #AmnioWrap #Biotech #PressRelease #Biostem #BSEM
BioStem Technologies retweeted
Exciting Update! BioStem Technologies (OTC: BSEM) is now collaborating with PCG Advisory to enhance its strategic investor relations. Our combined focus? Amplify BioStem's visibility and growth in the investment community. bit.ly/3Pna6tt
#BioStemTechnologies $BSEM @pcgadvisory
BioStem Technologies retweeted
$BSEM @BSEM_Tech BioStem Technologies Engages PCG Advisory for Strategic Investor Relations - Press Release: bit.ly/46iPE3Z #OTC #OTCMarkets #StockMarket #PrismMediaWire #PressRelease #BioStem #BSEM #Healthcare #Biotech #PCGAdvisory PRISM MediaWire - Bios: bit.ly/m/prismmediawire
BioStem Technologies retweeted
NovaBay has entered an agreement with @BSEM_Tech, under which NovaBay has been granted the right to commercialize BioStem's’ Amniotic Tissue Allograft, which is intended for use as a protective covering during the repair of ocular surfaces. bit.ly/3LGdBKL $NBY $BSEM
BioStem Technologies retweeted
Justin Hall, CEO of NovaBay, highlights the Company's plans to commercialize @BSEM_Tech's Amniotic Tissue Allograft as Avenova® Allograft. For more information, visit: bit.ly/3LGdBKL $NBY $BSEM @AvenovaEyeCare
BioStem Technologies retweeted
BioStem Technologies Enters Into a Share Exchange Agreement $BSEM newsfilter.io/articles/biost…
BioStem Technologies retweeted
$BSEM - BioStem inks share exchange contract to buy back common stock of unit/manufacturing division seekingalpha.com/news/393575…
BioStem Technologies retweeted
$BSEM new alert at aheadsup.com/twitter/newsent… #Penny #pennystocks #PinkSheet #OTC #OTCBB #stocks 50
BioStem Technologies retweeted
**SPONSORSHIP PROMOTION** Showcase your organization and expertise at the leading #LifeSciences Conference OCT 11-13 in Ponte Vedra Beach, FL. Popular items are selling quickly! Contact us today! Sponsor #BioFL23 bit.ly/3Yr50jd
ALT https://www.bioflorida.com/page/About2023
BioStem Technologies retweeted
The Center for Medicare Services (CMS) established national pricing for @BSEM_Tech's VENDAJE in all Medicare Administrative Contractors (MAC) regions, effective Jan. 1, 2023 $BSEM
biotuesdays.com/2023/01/24/c…
BioStem Technologies retweeted
$BSEM BioStem Technologies sees opportunity in two growing markets tinyurl.com/2b73h2xe @BSEM_Tech #BSEM #healthcare #biotech #pharma
BioStem Technologies retweeted
$BSEM BioStem Technologies sees opportunity in two growing markets tinyurl.com/2a56sdcc @BSEM_Tech #BSEM
BioStem Technologies retweeted
MEMBER NEWS: Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation. View full news release: bit.ly/3j8igtb
